131 related articles for article (PubMed ID: 7706745)
1. Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis.
Groves RW; Giri J; Sims J; Dower SK; Kupper TS
J Immunol; 1995 Apr; 154(8):4065-72. PubMed ID: 7706745
[TBL] [Abstract][Full Text] [Related]
2. Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis.
Groves RW; Sherman L; Mizutani H; Dower SK; Kupper TS
Am J Pathol; 1994 Nov; 145(5):1048-56. PubMed ID: 7977638
[TBL] [Abstract][Full Text] [Related]
3. Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor.
Sadouk MB; Pelletier JP; Tardif G; Kiansa K; Cloutier JM; Martel-Pelletier J
Lab Invest; 1995 Sep; 73(3):347-55. PubMed ID: 7564267
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II interleukin-1 receptor cDNA.
Bristulf J; Gatti S; Malinowsky D; Bjork L; Sundgren AK; Bartfai T
Eur Cytokine Netw; 1994; 5(3):319-30. PubMed ID: 7524717
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction.
Mehraban F; Kasturi S
Arthritis Rheum; 1998 Mar; 41(3):515-24. PubMed ID: 9506580
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptors type I and type II are differentially regulated in human keratinocytes by ultraviolet B radiation.
Grewe M; Gyufko K; Budnik A; Ruzicka T; Olaizola-Horn S; Berneburg M; Krutmann J
J Invest Dermatol; 1996 Dec; 107(6):865-70. PubMed ID: 8941676
[TBL] [Abstract][Full Text] [Related]
8. Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity.
McKean DJ; Podzorski RP; Bell MP; Nilson AE; Huntoon CJ; Slack J; Dower SK; Sims J
J Immunol; 1993 Oct; 151(7):3500-10. PubMed ID: 8376789
[TBL] [Abstract][Full Text] [Related]
9. Human aortic endothelial cells express the type I but not the type II receptor for interleukin-1 (IL-1).
Akeson AL; Mosher LB; Woods CW; Schroeder KK; Bowlin TL
J Cell Physiol; 1992 Dec; 153(3):583-8. PubMed ID: 1360015
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C modulates the amounts of IL-1 receptor mRNA in human lung fibroblasts.
Aksamit TR; Monick MM; Hunninghake GW
J Immunol; 1993 Jul; 151(1):284-90. PubMed ID: 8326129
[TBL] [Abstract][Full Text] [Related]
11. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids.
Levine SJ; Wu T; Shelhamer JH
J Immunol; 1997 Jun; 158(12):5949-57. PubMed ID: 9190949
[TBL] [Abstract][Full Text] [Related]
12. IL-1 receptor accessory protein is an essential component of the IL-1 receptor.
Cullinan EB; Kwee L; Nunes P; Shuster DJ; Ju G; McIntyre KW; Chizzonite RA; Labow MA
J Immunol; 1998 Nov; 161(10):5614-20. PubMed ID: 9820540
[TBL] [Abstract][Full Text] [Related]
13. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma.
Goodman RE; Nestle F; Naidu YM; Green JM; Thompson CB; Nickoloff BJ; Turka LA
J Immunol; 1994 Jun; 152(11):5189-98. PubMed ID: 7910619
[TBL] [Abstract][Full Text] [Related]
15. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
16. Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes.
Deyerle KL; Sims JE; Dower SK; Bothwell MA
J Immunol; 1992 Sep; 149(5):1657-65. PubMed ID: 1387148
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a low molecular weight isoform of IL-1 receptor antagonist.
Malyak M; Guthridge JM; Hance KR; Dower SK; Freed JH; Arend WP
J Immunol; 1998 Aug; 161(4):1997-2003. PubMed ID: 9712072
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an intracellular activation loop in the IL-1 system.
Hofmeister R; Männel DN; Falk W
J Inflamm; 1995-1996; 47(3):151-63. PubMed ID: 9117442
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 (IL-1) receptors on murine splenic B cells and the 70Z/3 pre-B-cell line appear to be identical and bind human IL-1 alpha and IL-1 beta differentially.
Powers GD; Varnell TA; Kaffka KL; Chizzonite R; Kilian PL
Lymphokine Cytokine Res; 1992 Apr; 11(2):123-32. PubMed ID: 1533794
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]